198 related articles for article (PubMed ID: 33531688)
1. Prognostic significance of esterase gene expression in multiple myeloma.
Kumari R; Majumder MM; Lievonen J; Silvennoinen R; Anttila P; Nupponen NN; Lehmann F; Heckman CA
Br J Cancer; 2021 Apr; 124(8):1428-1436. PubMed ID: 33531688
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA-seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma.
He H; Li Z; Lu J; Qiang W; Jiang S; Xu Y; Fu W; Zhai X; Zhou L; Qian M; Du J
Clin Transl Med; 2022 Mar; 12(3):e757. PubMed ID: 35297204
[TBL] [Abstract][Full Text] [Related]
3. High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma.
Steiner N; Hajek R; Sevcikova S; Borjan B; Jöhrer K; Göbel G; Untergasser G; Gunsilius E
PLoS One; 2017; 12(7):e0181487. PubMed ID: 28727816
[TBL] [Abstract][Full Text] [Related]
4. Using MMRFBiolinks R-Package for Discovering Prognostic Markers in Multiple Myeloma.
Settino M; Cannataro M
Methods Mol Biol; 2022; 2401():289-314. PubMed ID: 34902136
[TBL] [Abstract][Full Text] [Related]
5. Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.
Laganà A; Perumal D; Melnekoff D; Readhead B; Kidd BA; Leshchenko V; Kuo PY; Keats J; DeRome M; Yesil J; Auclair D; Lonial S; Chari A; Cho HJ; Barlogie B; Jagannath S; Dudley JT; Parekh S
Leukemia; 2018 Jan; 32(1):120-130. PubMed ID: 28642592
[TBL] [Abstract][Full Text] [Related]
6. The role of pentraxin 3 and oxidative status in the prognosis of multiple myeloma.
Oğuzman H; Kaçmaz M
J Investig Med; 2024 Apr; 72(4):333-340. PubMed ID: 38373952
[TBL] [Abstract][Full Text]
